Sarepta Therapeutics
SRPT
#1565
Rank
โ‚น954.90 B
Marketcap
โ‚น9,997
Share price
-1.75%
Change (1 day)
-0.23%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚น311.72 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total assets are โ‚น311.72 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sarepta Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚น271.77 B4.98%
2022-12-31โ‚น258.87 B10.48%
2021-12-31โ‚น234.30 B7.34%
2020-12-31โ‚น218.28 B67.93%
2019-12-31โ‚น129.98 B13.21%
2018-12-31โ‚น114.81 B37.48%
2017-12-31โ‚น83.51 B189.78%
2016-12-31โ‚น28.81 B58.4%
2015-12-31โ‚น18.19 B-2.7%
2014-12-31โ‚น18.69 B3.81%
2013-12-31โ‚น18.01 B60.49%
2012-12-31โ‚น11.22 B290.25%
2011-12-31โ‚น2.87 B39.6%
2010-12-31โ‚น2.06 B-26.03%
2009-12-31โ‚น2.78 B126.93%
2008-12-31โ‚น1.22 B-19.06%
2007-12-31โ‚น1.51 B-16.22%
2006-12-31โ‚น1.80 B-28.7%
2005-12-31โ‚น2.53 B105.52%
2004-12-31โ‚น1.23 B-42.46%
2003-12-31โ‚น2.14 B56.49%
2002-12-31โ‚น1.37 B-15.93%
2001-12-31โ‚น1.63 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚น4.721 T 1,414.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น148.28 B-52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น142.07 B-54.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น42.53 B-86.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น364.11 B 16.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น159.52 B-48.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น177.76 B-42.97%๐Ÿ‡บ๐Ÿ‡ธ USA